Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs

By Aich Udayanath   Meledeo M.   Sampathkumar Srinivasa-Gopalan   Fu Jie   Jones Mark   Weier Christopher   Chung Sung   Tang Benjamin   Yang Ming   Hanes Justin   Yarema Kevin  

Glycoconjugate Journal, Vol. 27, Iss. 4, 2010-05 ,pp. : 445-459

Springer Publishing Company

Access to resources Recommend Favorite

Structure-based Identification of a Ricin Inhibitor

By Yan X.   Hollis T.   Svinth M.   Day P.   Monzingo A.F.   Milne G.W.A.   Robertus J.D.  

Journal of Molecular Biology, Vol. 266, Iss. 5, 1997-03 ,pp. : 1043-1049

Academic Press

Access to resources Recommend Favorite

Inhibition of the CD28-CD80 co‐stimulation signal by a CD28‐binding affibody ligand developed by combinatorial protein engineering

By Sandström K.   Xu Z.   Forsberg G.   Nygren P.‐Å.  

Protein Engineering, Vol. 16, Iss. 9, 2003-09 ,pp. : 691-697

Oxford University Press

Access to resources Recommend Favorite

Identification of Three Alternatively Spliced Variants of Human CD28 mRNA

By Magistrelli G.   Jeannin P.   Elson G.   Gauchat J-F.   NGuyen T.N.G.   Bonnefoy J-Y.   delneste Y.  

Biochemical and Biophysical Research Communications, Vol. 259, Iss. 1, 1999-05 ,pp. : 34-37

Elsevier

Access to resources Recommend Favorite

Development of a Recombinant Bacterial Expression System for the Active Form of a Human Transforming Growth Factor β Type II Receptor Ligand Binding Domain

By Boesen C.C.   Motyka S.A.   Patamawenu A.   Sun P.D.  

Protein Expression and Purification, Vol. 20, Iss. 1, 2000-10 ,pp. : 98-104

Academic Press

Access to resources Recommend Favorite